➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Merck
Moodys
Boehringer Ingelheim

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Vonoprazan

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Vonoprazan?

Vonoprazan is an investigational drug.

There have been 18 clinical trials for Vonoprazan. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2019.

The most common disease conditions in clinical trials are Esophagitis, Gastroesophageal Reflux, and Helicobacter Infections. The leading clinical trial sponsors are Takeda, Phathom Pharmaceuticals, Inc., and Hamamatsu University.

There are eighteen US patents protecting this investigational drug and one hundred and sixty-two international patents.

Recent Clinical Trials for Vonoprazan
TitleSponsorPhase
Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy VolunteersSeoul National University HospitalPhase 1
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy ParticipantsPhathom Pharmaceuticals, Inc.Phase 1
Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy ParticipantsPhathom Pharmaceuticals, Inc.Phase 1

See all Vonoprazan clinical trials

Clinical Trial Summary for Vonoprazan

Top disease conditions for Vonoprazan
Top clinical trial sponsors for Vonoprazan

See all Vonoprazan clinical trials

US Patents for Vonoprazan

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vonoprazan   Start Trial 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same Takeda Pharmaceutical Company Limited (Osaka-Shi, JP)   Start Trial
Vonoprazan   Start Trial Proton pump inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Vonoprazan   Start Trial Method for producing sulfonyl chloride compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Merck
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.